Found 47 matching trials
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma
PHASE2The IO/TKI regimens which combines Immune checkpoint inhibitors (IO) with T...
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
N/AHepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and programme...
Location
Chinese PLA General hospital
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
PHASE2The investigators propose to initiate a study assessing the efficacy and sa...
Location
Peking Union Medical College Hospital
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
dTACE-HAIC Combined With Bevacizumab and Atezolizumab for Huge Hepatocellular Carcinoma
NAThis study intends to evaluate the efficacy and safety of drug-eluting tran...
Location
Chinese PLA General hospital
HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
PHASE2This is an open-label, single-arm clinical study to preliminarily observe a...
Location
Multiple Locations
Phase III Study of Toripalimab(JS001) Combined With Lenvatinib for Advanced HCC
PHASE3This is a prospective, randomized, placebo-controlled, double-blind, multic...
Status
Active Not Recruiting
Location
Qinhuai Medical Area, General Hospital of PLA Eastern Theater Command
Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC
N/ACombination treatment with antiangiogenic agents and anti-programmed cell d...
Location
Zhongshan Hospital, Fudan University
A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers
PHASE2This is a prospective, non-randomized, open-label, single-center phase II c...
Location
Multiple Locations
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2Purpose: This phase II clinical trial evaluates whether a combination of li...
Location
Multiple Locations